SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-19-000230
Filing Date
2019-07-12
Accepted
2019-07-15 09:24:17
Documents
1
Group Members
ARCH VENTURE FUND IX OVERAGE, L.P.ARCH VENTURE PARTNERS IX OVERAGE, L.P.ARCH VENTURE PARTNERS IX, L.P.ARCH VENTURE PARTNERS IX, LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND IX, L.P. - SCHEDULE 13D - KARUNA THERAPEUTICS, INC. karuna13d_18328.htm SC 13D 274046
  Complete submission text file 0001072613-19-000230.txt   275788
Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 773-380-6600
ARCH Venture Fund IX, L.P. (Filed by) CIK: 0001666306 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Subject) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91054 | Film No.: 19954228
SIC: 2834 Pharmaceutical Preparations